相关实验视频

Updated: Jun 19, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

TP53签名预测乳腺癌新辅助化疗后的病理完整反应:使用前性研究队列的观察和确认研究

Shin Takahashi¹, Nobuaki Sato², Kouji Kaneko²

¹Department of Medical Oncology, Tohoku University Hospital, Sendai, Japan; Department of Clinical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Translational oncology

|July 24, 2024

概括

TP53签名预测了对新辅助化疗 (NAC) 的反应和乳腺癌的存活率. 具有突变TP53特征的患者从NAC中获益更多,并且预后更好.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
乳腺癌研究研究乳腺癌研究

背景情况:

TP53签名是新辅助化疗 (NAC) 反应的已知预测因素,也是乳腺癌的预后因素.
在前性研究中验证其预测和预后能力对于临床应用至关重要.

研究的目的:

确认TP53签名能够预测经过NAC的乳腺癌患者的病理完整反应 (pCR) 和预后的能力.
开发和验证TP53签名诊断套件.

主要方法:

使用了回顾性和前性发展队列 (n=253) 和验证队列 (n=729),包括NAC治疗和化学疗法先前的患者.
开发了一个TP53签名诊断套件.
分析了PCRTP53特征的可预测性及其与无复发生存率 (RFS) 和整体生存率 (OS) 的相关性.

主要成果:

突变 (mt) TP53签名组与野生类型 (wt) 签名组相比显示出明显更高的pCR率 (OR=5.599,P=0.0008).
与wt签名患者相比,mt签名患者从NAC中获得了更大的RFS和OS益处.
后期分析表明,将capecitabine添加到NAC疗法中的生存益处可能仅限于mt签名组.

结论:

在乳腺癌中,TP53签名有效地预测了在NAC之后的pCR.
TP53签名识别了那些在RFS和OS方面更有可能从NAC中受益的患者.
这种特征有可能成为乳腺癌管理中的个性化治疗策略.

关键词:

乳腺癌乳腺癌乳腺癌新辅助化学疗法新辅助化学疗法病理完整反应的病理完整反应.预测因素是一个预测因素.这就是TP53的特点.

更多相关视频

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

High-Throughput Dissociation and Orthotopic Implantation of Breast Cancer Patient-Derived Xenografts

Published on: December 20, 2024

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...